AI-ECG Screening for Left Ventricular Systolic Dysfunction

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jan 21, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new way to screen for a heart condition called left ventricular systolic dysfunction, which affects how well the heart pumps blood. Researchers are testing an artificial intelligence (AI) program that analyzes electrocardiograms (ECGs), which are tests that measure the heart's electrical activity. The goal is to see if this AI can effectively identify patients who have this heart condition, potentially making it easier to diagnose and treat.

To participate in this trial, individuals aged 65 to 74 who can provide consent and complete specific heart tests (like a 12-lead ECG and an echocardiogram) would be eligible. Unfortunately, people under 18 or those who cannot participate for any reason decided by the study team cannot join. If you take part in this study, you can expect to undergo these heart tests with the hope that the findings will improve how we screen for heart issues in the future. This trial is not yet recruiting participants, so there will be more information available as it progresses.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals or those whose legal representative agree to participate in the study, and sign the consent form
• • Can complete both 12-lead electrocardiogram and transthoracic echocardiography
• Exclusion Criteria:
• • Individuals whose age is less than 18 year-old.
• • Individuals who do not agree to participate in the study
• • Patients who are unable to participate in clinical trials at the discretion of the investigator